A Multi-Site Study for Detection of the Factor V (Leiden) Mutation from Genomic DNA Using a Homogeneous Invader Microtiter Plate Fluorescence Resonance Energy Transfer (FRET) Assay-Reference-Cited by-同舟云学术

A Multi-Site Study for Detection of the Factor V (Leiden) Mutation from Genomic DNA Using a Homogeneous Invader Microtiter Plate Fluorescence Resonance Energy Transfer (FRET) Assay

Published:2000-05 Issue:2 Volume:2 Page:97-104
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Ledford Marlies,Friedman Kenneth D.,Hessner Martin J.,Moehlenkamp Cynthia,Williams Thomas M.,Larson Richard S.

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference28 articles.

1. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene;Dahlback;Haemostasis,1994

2. Resistance to activated protein C as a basis for venous thrombosis;Svensson;N Engl J Med,1994

3. Mutation in blood coagulation factor V associated with resistance to activated protein C;Bertina;Nature,1994

4. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families;Martinelli;Blood,1998

5. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis;Bertina;Thromb Haemost,1995

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of an Unlabeled Probe High-Resolution Melting Analysis Assay (HRMA) for Factor V Leiden 1691 G/A Mutation to a Fluorogenic 5′ Nuclease PCR Hydrolysis Assay;The Journal of Applied Laboratory Medicine;2024-05-22

2. Laboratory Diagnosis of Activated Protein C Resistance and Factor V Leiden;Seminars in Thrombosis and Hemostasis;2023-07-10

3. The Journal of Molecular Diagnostics;The Journal of Molecular Diagnostics;2019-11

4. The Journal of Molecular Diagnostics;The Journal of Molecular Diagnostics;2019-11

5. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A;Thrombosis Research;2019-10